AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc (NYSE:MRK), on Wednesday, announced long-term results from the OlympiA Phase 3 trial. The trial showed Lynparza (olaparib) demonstrated sustained ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

She wears a white tank top and denim skirt. Egg freezing is often sold by fertility clinics as an "insurance policy". But some experts say it's more like a lottery, and few women return to use ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The in vitro fertilization (IVF) market is expanding rapidly due to increasing infertility rates, lifestyle changes, and advancements in reproductive technologies. IVF, a cornerstone of assisted ...

It's worth mentioning that the Orum deal comes as Vertex has sued the US Government for failing to cover a fertility support programme for Casgevy, for example freezing and storing eggs.

German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its presence in the world's second-largest economy through increasing ...